INS and cancer: Together with metabolic disruptions in insulin signaling, this manifestation of immune dysfunction common to obesity and type 2 diabetes present a favorable environment for cancer cell proliferation, invasion, and survival (Allavena et al., 2008; van Kruijsdijk et al., 2009).